Nonablative Facial Skin Tightening

Nonablative Facial Skin Tightening

No Results

No Results

processing….

Reduction of rhytides and skin laxity can significantly contribute to improving overall facial appearance. Dermabrasion, chemical peels, and resurfacing lasers (eg, carbon dioxide laser, erbium:yttrium-aluminum-garnet [Er:YAG] laser) are the current mainstays of ablative facial resurfacing. During an ablative facial resurfacing process, the epidermis is denuded to a certain depth by the direct physical, chemical, or thermal injury applied to the skin.

The ablative cutaneous injury induces a healing response, resulting in the deposition of a new skin matrix with improved characteristics. During this so-called healing process, skin rejuvenation occurs by a proliferation of fibroblast activity, the action of inflammatory mediators, and a deposition of new collagen and other dermal matrix proteins.

Despite achieving appreciable clinical results, the adverse effects of ablative resurfacing modalities can result in significant edema and erythema that last for several weeks. The potential for impressive clinical improvements must be balanced against well-described morbidities (eg, protracted edema and erythema), long-term sequelae (eg, pigmentary changes), and potential complications (eg, scarring). As such, the typical prolonged recovery times and the potential problems associated with these ablative modalities may also limit their use in patients who desire a rejuvenation procedure with reduced downtime and a minimal risk profile. [1, 2]

In contrast to ablative rejuvenation procedures, nonablative laser rejuvenation procedures induce a dermal healing response without notable injury to the epidermis. Improving the appearance of the skin without injury to the epidermis is a hallmark of nonablative skin rejuvenation. The exact mechanisms of nonablative dermal remodeling are still under investigation; however, a subthreshold laser-induced injury to the dermis and/or the dermal vasculature theoretically results in a wound repair response, fibroblast stimulation, and collagen reformation.

The main nonablative laser rejuvenation modalities involve the application of mid-infrared lasers. Certain visible light lasers (VLLs), such as the pulse dye laser or the intense pulse light laser, have been shown to induce dermal remodeling in patients with lighter skin tones. These lasers are discussed for historical purposes in a later section of this article.

An increasing body of evidence suggests that lasers in the mid-infrared range may be the best choice for safe nonablative resurfacing on a wide range of skin types. This article focuses on the following mid-infrared lasers: the 1320-nm neodyminium:yttrium-aluminum-garnet (Nd:YAG) laser (CoolTouch, CoolTouch Corp, Roseville, Calif) and the 1064-nm Nd:YAG laser (Lyra, Laserscope, San Jose, Calif). [3]

The ideal nonsurgical rejuvenation method for the aging face is dependent on each patient’s skin type, rejuvenation goals, recovery time priorities, threshold for complications, and esthetic expectations. Influencing these important factors is the physician’s experience and familiarity with a particular rejuvenation modality. An ideal rejuvenation modality induces an improvement in the skin without causing injury to the epidermis.

Early reports in the mid to late 1990s demonstrated clinical improvement in the appearance of hypertrophic scars and stretch marks treated with VLLs without significant ablation of the epidermis. Such improvements were further supported by histologic evidence of decreased coarse collagen fibers and increased elastin formation in biopsy specimens.

Clinical and histologic improvement in the appearance of scars prompted investigators to evaluate the efficacy of VLLs in reducing actinically induced facial rhytides. In 1999, Zelickson noted an improvement in 9 out of 10 (90%) patients with mild-to-moderate rhytides and an improvement in 4 out of 10 (40%) patients with moderate-to-severe rhytides, all of whom were treated with VLLs. [4]

Corresponding histologic observations showed an increase in epidermal thickness and superficial organization of collagen and elastin content. Other studies with VLLs also demonstrated clinical improvements in dyspigmentation and erythema on the skin. Despite achieving appreciable clinical improvement, the reported adverse effects of using VLLs included significant bruising and swelling that lasted up to 2 weeks. Additionally, the affinity of VLLs for melanin limited their use in darker-skinned or tanned patients. See the image below.

Intense pulsed light (IPL) sources were initially successful in treating solar-induced changes on the face. Goldberg reported some improvement at 6-month follow-up in the quality of the skin in 25 of 30 (83%) patients who were treated with an IPL source with a 645-nm cutoff filter. [5] However, blistering occurred in 3 out of 30 (10%) patients who were treated with an IPL source.

In his treatment of patients with photodamaged skin, Bitter reported a success rate of greater than 90% in reducing their superficial irregular pigmentation, telangiectasias, and fine wrinkles. [6] He treated patients using an IPL source with a shortened wavelength (using a 550-nm cutoff filter), a short pulse width (creating less epidermal injury), and a multiple treatment regimen. Upon histologic evaluation of 1 patient at 4 weeks after the final treatment, Bitter identified new collagen formation in both the papillary dermis and the reticular dermis. Bitter also reported a high rate (88%) of patient satisfaction, with no incidences of purpura; he described this finding as one of the advantages of using IPL sources instead of pulsed dye lasers.

Despite the encouraging findings of such reports, a number of limitations exist. The disadvantages of using an IPL source include the absence of an inherent skin-cooling protective mechanism, the need to learn specialized techniques to minimize or avoid epidermal injury, and the large size of the IPL device. Most importantly, the designated 550-nm wavelength is strongly attracted to melanin, limiting its use in darker-skinned patients and increasing the risk of skin burns in tanned patients.

According to The American Society for Aesthetic Plastic Surgery, IPL laser treatment was the fourth most common nonsurgical cosmetic procedure for men in the United States. [7]

Laser energy in the near- and mid-infrared locations on the spectrum is weakly attracted to melanin. When epidermal melanin is bypassed more efficiently, patients with all skin types can be treated with reduced risk. Also, by extending the wavelength of the selected laser to the infrared and mid-infrared areas, deeper energy penetration can be achieved, and laser energy can be delivered to the dermis. The epidermis is bypassed, and the heat that is produced by laser energy is nonselectively deposited in the dermis. Theoretically, heat-induced dermal injury eventually results in the activation of dermal fibroblasts and the induction of a healing response. An inflammatory response within the dermis to the laser-generated heat hypothetically initiates a reaction that leads to collagen remodeling and an improvement in the appearance of facial rhytides.

Early studies with the 1320-nm Nd:YAG laser demonstrated histologic evidence of dermal collagen homogenization, indicating the occurrence of a degree of dermal remodeling. However, the use of the 1320-nm Nd:YAG laser without a skin-cooling device produced discouraging clinical results. Moreover, the clinical risk profile of this modality included pitted scars and hyperpigmentation that occurred at a rate of 30% and 40%, respectively.

Coupling the 1320-nm Nd:YAG laser handpiece with a thermal sensor and a cooling cryogen blast allows the surgeon to better control the surface temperature of the skin. The laser is able to induce greater thermal stimulation of dermal fibroblasts within the papillary dermis and the mid-reticular dermis, while the epidermis is cooled and and protected from direct thermal injury.

Cooling the skin and delivering the laser pulse can be coordinated in numerous theoretical ways, that is, skin cooling prior to, during, or immediately after laser pulse delivery to optimize treatment. In this manner, the temperature of the dermis can increase to 60-70°C, while the temperature of the epidermal surface can be safely maintained at 40-48°C. As observed clinically, effective cooling of the skin can minimize the risks of scarring and hyperpigmentation. With strict control of the surface temperature, the risk of pigmentation changes seems to be averted, even in Fitzpatrick skin types IV and V.

Kelly et al were among the first to publish their experience in treating facial rhytides with the 1320-nm Nd:YAG laser coupled with a cryogen spray. [8, 9] This initial study demonstrated statistically significant improvement at 3-month follow-up; however, at 6-month follow-up, only patients with severe rhytides retained their previously observed improvements.

Pham applied the 1320-nm Nd:YAG laser with a thermal sensor and a cryogen cooling spray to the rejuvenation of darker skin types (Fitzpatrick skin types III, IV, and V) in Asian patients. [10] Pham noted an improvement in periorbital rhytides at 6 months in all (of 4) patients who had undergone serial (multiple) treatments. He also noted no complications or adverse effects, except for transient erythema. Clinical observation did not reveal any cases of hyperpigmentation. Histologic evaluation of biopsy specimens taken 2 weeks after treatment did not show any increase in melanin content.

Pham’s experience highlighted the need for a multiple treatment regimen. Of those who were treated once, only 2 out of 8 (25%) patients demonstrated an improvement at 6-month follow-up; even the improvements observed in these patients were not found to be statistically significant.

The extended pulse 1064-nm Nd:YAG laser is a safe and proven technology that has been effectively used in laser epilation in patients of all skin types and colors. Similar to the 1320-nm Nd:YAG laser, the 1064-nm wavelength deposits nonselective heat into the dermis with a minimal affinity for melanin. The advantages of this modality for wrinkle reduction include the technical ease of performing the procedure, minimal to no patient discomfort, and the ability to treat all skin types with little risk of epidermal injury.

Goldberg’s side-by-side comparisons of perioral rhytides treated with an IPL source and the 1064-nm Nd:YAG laser revealed similar improvement in rhytid reduction, with the Nd:YAG laser being better tolerated by patients. [11] Additionally, although not statistically significant, patients who were treated with the Nd:YAG laser subjectively described an improvement in rhytid reduction that lasted up to 24 weeks following their final treatment.

In a 2003 study by Dayan et al involving 51 patients over a 4-month period, treatment with the 1064-nm Nd:YAG laser coupled to a cooling handpiece produced improvement in several skin quality parameters. [12] Thirty-four patients completed a minimum of 7 treatments, which were spaced in 1- to 4-week intervals, with the favored interval being every 2 weeks.

Treatments were initiated using a 10-mm handpiece at a setting of 22 J/cm2, a 50-millisecond pulse width, and a frequency of 2 pulses per second. These settings were chosen based on the following theoretical reasons: the energy was below the threshold level for melanin follicular damage, the pulse width was extended beyond the thermal relaxation time of skin melanin (3-10 milliseconds), and the overall energy would produce enough heat for a subthreshold injury to the surrounding dermis.

Blinded physician analysis based on pretreatment and posttreatment photographs demonstrated subtle (and statistically significant) decreases in coarse wrinkles, skin laxity, and overall improvement scores. Patient self-assigned subjective scores declined after 6 treatments in relation to coarse wrinkles, skin laxity, and overall improvement. In this study, no complications were encountered, the anesthetic needs of the patients were minimal to nonexistent, and the laser operators described a shallow learning curve. While improvements in photodamaged skin were subtle and gradual, the laser was well tolerated by patients of all skin types. Anesthesia requirements for the patients were minimal, and patients did not require any pharmacologic intervention.

Although not part of this study, the authors reported no blister formation, prolonged erythema, scarring or dyspigmentation (regardless of skin type), or any major adverse reactions in over 500 facial treatments using the 1064-nm Nd:YAG laser. The conclusion of this study was that nonablative resurfacing techniques using the 1064-nm Nd:YAG laser coupled with a cooling handpiece were well suited for patients who request facial rejuvenating treatments with minimal downtime.

Nonablative resurfacing techniques are well suited for patients who request rejuvenating treatments of the aging face. Regardless of the laser type, improvements in fine lines, wrinkles, and photodamaged skin are subtle and gradual. While many different lasers and nonlaser light sources are being investigated in an attempt to identify the favored modality, the extended pulse Nd:YAG lasers provide particular benefits. However, both the 1320-nm Nd:YAG laser and the 1064-nm Nd:YAG laser when coupled with a skin-cooling device are unique in that they are well tolerated by patients of all skin types. Furthermore, at this time, these treatments have been found to be safe.

Nonablative laser treatments, while desirable, have yet to replace proven resurfacing techniques or standard surgical procedures for facial rejuvenation. A literature review by Kauvar suggested that skin-tightening procedures using fractional nonablative lasers have produced inconsistent clinical results. [13] Patients with moderate-to-severe rhytidosis still need surgical or ablative skin-tightening procedures for appreciable facial rejuvenation.

(A study by Alshami indicated that the 1064-nm Nd:YAG laser can also be successfully used for ablative skin resurfacing. In the study, of 296 patients with Fitzpatrick skin types III-IV, 30-80% improvement was seen following ablative therapy with this laser, with patients experiencing shorter recovery and treatment times than occur with carbon dioxide and Er:YAG lasers. [14] )

Further studies and histologic evaluations are necessary to determine the ideal settings to achieve long-term benefits from and minimize possible sequelae of these nonablative modalities. Moreover, the lack of long-term follow-up hinders the ability to evaluate the long-term safety record of these new treatment modalities. Nevertheless, nonablative rejuvenation may provide an attractive alternative for the person who is unable to afford the downtime of more aggressive procedures and is dissatisfied with the minimal gains achieved from superficial peels and microdermabrasion.

Vanaman M, Fabi SG, Carruthers J. Complications in the Cosmetic Dermatology Patient: A Review and Our Experience (Part 1). Dermatol Surg. 2016 Jan. 42 (1):1-11. [Medline].

Vanaman M, Fabi SG, Carruthers J. Complications in the Cosmetic Dermatology Patient: A Review and Our Experience (Part 2). Dermatol Surg. 2016 Jan. 42 (1):12-20. [Medline].

Goldman A, Wollina U, de Mundstock EC. Evaluation of Tissue Tightening by the Subdermal Nd: YAG Laser-Assisted Liposuction Versus Liposuction Alone. J Cutan Aesthet Surg. 2011 May. 4(2):122-8. [Medline]. [Full Text].

Zelickson BD, Kilmer SL, Bernstein E, et al. Pulsed dye laser therapy for sun damaged skin. Lasers Surg Med. 1999. 25(3):229-36. [Medline].

Goldberg DJ, Cutler KB. Nonablative treatment of rhytides with intense pulsed light. Lasers Surg Med. 2000. 26(2):196-200. [Medline].

Bitter PH. Noninvasive rejuvenation of photodamaged skin using serial, full-face intense pulsed light treatments. Dermatol Surg. 2000 Sep. 26(9):835-42; discussion 843. [Medline].

The American Society for Aesthetic Plastic Surgery. Liposuction No Longer the Most Popular Surgical Procedure According to New Statistics. The American Society for Aesthetic Plastic Surgery. Available at http://www.surgery.org/press/news-release.php?iid=517. Accessed: 3/18/2009.

Kelly KM, Nelson JS, Lask GP, Geronemus RG, Bernstein LJ. Cryogen spray cooling in combination with nonablative laser treatment of facial rhytides. Arch Dermatol. 1999 Jun. 135(6):691-4. [Medline].

Kono T, Kikuchi Y, Groff WF, Sakurai H, Yamaki T. Split-face comparison study of cryogen spray cooling versus pneumatic skin flattening in skin tightening treatments using a long-pulsed Nd:YAG laser. J Cosmet Laser Ther. 2010 Apr. 12(2):87-91. [Medline].

Pham RT. Nonablative laser resurfacing. Facial Plast Surg Clin North Am. 2001 May. 9(2):303-10, ix. [Medline].

Goldberg DJ, Samady JA. Intense pulsed light and Nd:YAG laser non-ablative treatment of facial rhytides. Lasers Surg Med. 2001. 28(2):141-4. [Medline].

Dayan SH, Vartanian AJ, Menaker G, Mobley SR, Dayan AN. Nonablative laser resurfacing using the long-pulse (1064-nm) Nd:YAG laser. Arch Facial Plast Surg. 2003 Jul-Aug. 5(4):310-5. [Medline].

Kauvar AN. Fractional nonablative laser resurfacing: is there a skin tightening effect?. Dermatol Surg. 2014 Dec. 40 Suppl 12:S157-63. [Medline].

Alshami MA. New application of the long-pulsed Nd-YAG laser as an ablative resurfacing tool for skin rejuvenation: a 7-year study. J Cosmet Dermatol. 2013 Sep. 12(3):170-8. [Medline].

Bjerring P, Clement M, Heickendorff L, Egevist H, Kiernan M. Selective non-ablative wrinkle reduction by laser. J Cutan Laser Ther. 2000 Mar. 2(1):9-15. [Medline].

Newman J. Nonablative laser skin tightening. Facial Plast Surg Clin North Am. 2001 Aug. 9(3):343-9. [Medline].

A John Vartanian, MD, MS, FACS Assistant Clinical Professor, Department of Surgery, Division of Head and Neck, University of California, Los Angeles, David Geffen School of Medicine; Instructor, Department of Otolaryngology-Head and Neck Surgery, University of Southern California Keck School of Medicine

A John Vartanian, MD, MS, FACS is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American College of Surgeons, American Medical Association, American Academy of Otolaryngology-Head and Neck Surgery

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Dominique Dorion, MD, MSc, FRCSC, FACS Deputy Dean and Associate Dean of Resources, Professor of Surgery, Division of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, Université de Sherbrooke, Canada

Disclosure: Nothing to disclose.

Arlen D Meyers, MD, MBA Professor of Otolaryngology, Dentistry, and Engineering, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Head and Neck Society

Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Cerescan;RxRevu;Cliexa;Preacute Population Health Management;The Physicians Edge<br/>Received income in an amount equal to or greater than $250 from: The Physicians Edge, Cliexa<br/> Received stock from RxRevu; Received ownership interest from Cerescan for consulting; for: Rxblockchain;Bridge Health.

J David Kriet, MD, FACS Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Director of Facial Plastic and Reconstructive Surgery, University of Kansas School of Medicine

J David Kriet, MD, FACS is a member of the following medical societies: Society of University Otolaryngologists-Head and Neck Surgeons, AO Foundation, Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Cleft Palate-Craniofacial Association, American College of Surgeons, American Medical Association

Disclosure: Received honoraria from AO North America for speaking and teaching.

Steven H Dayan, MD Clinical Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, University of Illinois

Disclosure: Nothing to disclose.

Nonablative Facial Skin Tightening

Research & References of Nonablative Facial Skin Tightening|A&C Accounting And Tax Services
Source